MXPA04012913A - Pasteurisation process for microbial cells and microbial oil. - Google Patents
Pasteurisation process for microbial cells and microbial oil.Info
- Publication number
- MXPA04012913A MXPA04012913A MXPA04012913A MXPA04012913A MXPA04012913A MX PA04012913 A MXPA04012913 A MX PA04012913A MX PA04012913 A MXPA04012913 A MX PA04012913A MX PA04012913 A MXPA04012913 A MX PA04012913A MX PA04012913 A MXPA04012913 A MX PA04012913A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- temperature
- microbial
- minute
- pasteurization
- Prior art date
Links
- 238000009928 pasteurization Methods 0.000 title claims abstract description 89
- 230000000813 microbial effect Effects 0.000 title claims abstract description 67
- 238000000034 method Methods 0.000 title claims description 49
- 238000010438 heat treatment Methods 0.000 claims abstract description 64
- 238000001816 cooling Methods 0.000 claims abstract description 28
- 150000002978 peroxides Chemical class 0.000 claims abstract description 10
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 52
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 46
- 235000021342 arachidonic acid Nutrition 0.000 claims description 22
- 229940114079 arachidonic acid Drugs 0.000 claims description 22
- 238000000605 extraction Methods 0.000 claims description 11
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 7
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 7
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 7
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 4
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims description 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 241000826860 Trapezium Species 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 75
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 41
- 238000000855 fermentation Methods 0.000 description 22
- 230000004151 fermentation Effects 0.000 description 22
- 239000000203 mixture Substances 0.000 description 15
- 241000233866 Fungi Species 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 235000010633 broth Nutrition 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000002028 Biomass Substances 0.000 description 9
- 239000010779 crude oil Substances 0.000 description 9
- 241000195493 Cryptophyta Species 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 235000021588 free fatty acids Nutrition 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 150000003626 triacylglycerols Chemical class 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 241000907999 Mortierella alpina Species 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 238000007670 refining Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 241000199914 Dinophyceae Species 0.000 description 3
- 241000235648 Pichia Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 2
- 241001465318 Aspergillus terreus Species 0.000 description 2
- 241000235548 Blakeslea Species 0.000 description 2
- 241000235553 Blakeslea trispora Species 0.000 description 2
- 241000199913 Crypthecodinium Species 0.000 description 2
- 241000235575 Mortierella Species 0.000 description 2
- 241000235400 Phycomyces Species 0.000 description 2
- 241000186429 Propionibacterium Species 0.000 description 2
- 241000233675 Thraustochytrium Species 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- ADHNUPOJJCKWRT-JLXBFWJWSA-N (2e,4e)-octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCC\C=C\C=C\C(O)=O ADHNUPOJJCKWRT-JLXBFWJWSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100352919 Caenorhabditis elegans ppm-2 gene Proteins 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000199912 Crypthecodinium cohnii Species 0.000 description 1
- 241001480508 Entomophthora Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000764238 Isis Species 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241000235388 Mucorales Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000206618 Porphyridium Species 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- 241000197220 Pythium insidiosum Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241001276012 Wickerhamomyces ciferrii Species 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 150000002066 eicosanoids Chemical class 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- -1 fatty acid ester Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 239000002035 hexane extract Substances 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007472 neurodevelopment Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000011085 pressure filtration Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003595 thromboxanes Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
- A23L31/10—Yeasts or derivatives thereof
- A23L31/15—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/005—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6432—Eicosapentaenoic acids [EPA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6434—Docosahexenoic acids [DHA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Sustainable Development (AREA)
- Dermatology (AREA)
- Animal Husbandry (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
An improved pasteurisation protocol for pasteurising microbial cells is disclosed. The protocol has three stages, a first heating stage, a second plateau stage at which the cells are held at a (maximum and) constant temperature, and a third cooling stage. Both the heating and the cooling stages are rapid, with the temperature of the cells passing through 40 to 80 degree C in no more than 30 minutes in the heating stage. The heating rate is at least 0.5 degree C/minute and during cooling is at least -0.5 degree C/minute. The plateau maximum temperature is from 70 to 85 degree C. By plotting the pasteurisation protocol on a time (t, minutes) versus temperature (T, degree C) graph, one obtains a trapezium having an area less than 13,000 degree C minute. Not only does this result in a smaller energy input (and so a reduction in costs), but a better quality (and less oxidised) oil results having a peroxide value (POV) of less than 1.5 and an anisidine value (AnV) of less than 1.0.
Description
PASTEURIZATION PROCESS FOR MICROBIAL CELLS AND MICROBIAL OILS
Field of the Invention The present invention relates to a process for pasteurizing microbial cells comprising heating the cells from 40 ° C to 70 ° C in no more than 30 minutes. The heating rate during the pasteurization process can be at least 0.5 ° C / minute. The pasteurization process can comprise three stages, namely a heating step, a plateau stage (where the cells are kept at a constant temperature) and a heating step. If the pasteurization protocol is plotted, the area under the graph time (in minutes) versus temperature (° C) is less than 13,000 ° C minute. After pasteurization, polyunsaturated fatty acids (PUFA), such as arachidonic acid, or microbial oils can be extracted from the cells. The oil may contain a low peroxide value (POV) and / or a low anisidine (AnV) index. BACKGROUND OF THE INVENTION Polyunsaturated fatty acids, or PUFAs, are found naturally and a wide variety of different PUFAs are produced by different simple cellular organisms (algae, fungi, etc.). In particular, an important PUFA is arachidonic acid (AA), which is one of the members of long-chain polyunsaturated fatty acids (LC-PUFAs). Chemically, arachidonic acid is cis -5,8,11,14 eicosatetraenoic acid (20: 4) and belongs to the family (n-6) of LC-PUFAs. Arachidonic acid is the main precursor of a wide variety of biologically active compounds known collectively as eicosanoids, a group comprising prostaglandins, thromboxanes and leukotrienes. Arachidonic acid is also one of the components of the lipid fraction of human breast milk and is essential for the optimal neurological development of children. Arachidonic acid has a wide variety of different applications including its use in formulas for infants, food and animal feed. WO-A-97/37032 (Gist-Brocades) refers to the preparation of a microbial oil containing PUFAs from the pasteurized biomass. However, it does not disclose rapid heating to a temperature at which pasteurization takes place, or cooling therefrom. In addition, it does not take into account the total amount of energy used during the pasteurization process. Both, WO-A-00/15045 and WO-A-01/67886, relate to the use of Mucous fungi for use in the preparation of edibles. The first of these documents refers to the need to perform a reduction of the RNA before including the cells in a food and suggests a heating step. The second document suggests that a heating step to reduce the RNA content can be avoided by leaving the fungal cells stored in the container and allowing them to "mature". The application of the international patent No. PCT / EP01 / 08902 refers to the process for preparing blends of oils by combining oils containing crude PUFAs -6 with crude co-3 to produce a mixture of oils and then to the purification of the mixture of crude oils. Processes that involve the heating of biomass or microbial cells are known. From WO-A-97/37032, it is also known that microbial cells can be pasteurized prior to the extraction of a PUFA in the form of an oil. However, the present applicants have found that a new pasteurization process can improve the quality of an oil that can be extracted from the pasteurized cells. In particular, the resulting oil may be oxidized less, or be less oxidizable, and may have a low peroxide index (POV) and / or a low anisidine index (AnV). In addition, applicants have found that this new pasteurization process is more efficient because it requires less energy. Thus, the process is advantageous because not only can it improve the quality of the oil, but it can also reduce costs since it requires less energy. BRIEF DESCRIPTION OF THE FIGURES Figure 1 is a graph of temperature (° C) as a function of time (minutes) for three pasteurization protocols (A and C are within the invention, B is provided for comparison). Figure 2 is a graph of temperature (° C) as a function of time (minutes) for pasteurizations at three different plateau temperatures (40, 70 and 85 ° C). Figures 2 and 4 are graphs of AnV (and PUV of Fig.3) as a function of time (hours). Figure 5 is a plot of POV (meq / kg) and AnV as a function of temperature for pasteurizations at two different (plateau / stay) times (8 and 300 seconds). Figures 6 and 7 are temperature graphs (° C) as a function of time (seconds) for two different (plateau / permanence) times (8 seconds for Figure 6, 5 minutes for Figure 7) at five different temperatures (60 , 80, 100, 120 and 140 ° C).
Description of the Invention The present invention, therefore, provides an improved microbial cell pasteurization process. As the pasteurization process of the invention requires less energy it can allow a better quality of a product. Thus, a first aspect of the present invention relates to a process for the pasteurization of microbial cells, the process comprises heating the cells (at temperatures they comprise) from 40 ° C to (60 ° C or 70 ° C in no more than 30 minutes or the heating of the cells at a speed of at least 0.5 ° C / minute.Therefore, this aspect provides a rapid heating of the microbial cells during pasteurization and such a high heating rate is not disclosed in the matter While the matter provides pasteurization temperatures, there is no appreciation or discussion of the heating rate, or that this parameter could be important and that a relatively fast speed can provide benefits.Indeed, the high heating rates are intuitively against, as it can be expected to cause oxidation or, on the other hand, degradation of PUFAs or oils that can be extracted from the cells the .
A second aspect of the second invention relates to a process for the pasteurization of microbial cells, the process encompassing a pasteurization protocol comprising (at least) three stages. They are, namely: a (first) heating step, a (second) stage plateau (in which the microbial cells are left at a desired temperature or where the cells are kept at a constant and / or maximum temperature), and a (third) stage of enfilation. This aspect of the invention is referred to as a three stage pasteurization protocol. If this protocol is taken to a graph of time versus temperature a trapezoid may result. A third aspect of the invention relates to a pasteurization process for microbial cells, the process comprises the use of a pasteurization protocol such that the area included in the graph of time (minutes) versus temperature (° C) is less than 13,000 ° C. minute. The area below the graph of time versus temperature provides the amount of energy consumed in heating the cells during the pasteurization process. It has been found that rapid heating and / or rapid cooling of the cells (corresponding to the first and the third stage of the second aspect, respectively) can provide advantages, such as a better quality oil. In addition, the amount of energy required for the pasteurization process can be reduced compared to pasteurization processes described in the art. This third aspect concerns the input energy required for the pasteurization process. A fourth aspect of the invention relates to a process for pasteurizing microbial cells, the process comprises (heating the cells and thus) maintaining the cells at an elevated temperature (T, ° C) for a time (t, minutes) , for example, in a plateau stage, where the product tT (ie the multiplication of the time and temperature parameters, for example, during the plateau stage) is from 140 to 100,800 ° C. minute. As can be appreciated, this fourth aspect is similar to the second aspect in that it contains a plateau stage. The cells here can be left at a constant or maximum temperature. The product tT can thus represent the area below the time versus temperature graph for this plateau stage. First Aspect - Rapid Heating In this aspect the cells are heated to those temperatures at which the cells pass through or from 40 ° C to 70 ° C in no more than 30 minutes (as well as no more than 15 minutes). Preferably the time taken to go from 40 to 70 ° C should be no more than 40 to 50 minutes.
Alternatively or in addition, the cells are heated at a speed of at least 0.5 ° C / minute. Of course, the microbial cells can be (or be heated) at a temperature below 40 ° C. For example, the cells can start at room temperature or in the room. The cells may be at the fermentation temperature, such as at 30 ° ± 5 ° C. Thus, cells can be from 20 to 40 ° C, as well as from 23 to 27 ° C (or from 25 or 29 to 32 or 37 ° C) when heating (pasteurization) begins. In some cases the microbial cells can be cooled, for example, after the end of a fermentation. Thus, the cells can have an (initial) temperature of 5 to 10 ° C, as well as, of 7 to 9 ° C when the heating begins. The microbial cells can therefore be heated until their temperatures are below (60 o) 70 ° C. Thus, this may not be the final temperature of the microbial cells during pasteurization. In effect, the cells can be heated to a temperature below (60 o) 70 ° C. The temperature can be raised to a temperature of 70 to 90, 110 or 130 ° C, as well as, from 75 to 87 ° C and optimally rises from 78 to 84 ° C. The maximum temperature during pasteurization can be within these ranges, but for some embodiments can reach up to 100, 120 or 140 ° C. Preferably the cells are left or maintained at that (maximum) temperature. From now on it can be recognized that the cells can be heated to a lower temperature, or start, from 40 ° C to a temperature of 70 ° C or higher. The range of 40 to 70 ° C can provide a "strong shot" in extending the heating / temperature range for which a time (and thus a range) can be specified (and thus calculated). It can be calculated that the heating (from 40 to 70 ° C in 30 minutes) is at a speed of 1 ° C / minute. However, if necessary, the speed can be lowered slightly and in the first aspect rapid heating means a heating rate greater than 0.5 ° C / minute. Preferably, the speed is at least 0.6; 1.0 or equal to 1.5 ° C / minute. However, particularly rapid heating rates are contemplated, depending on the equipment and the volume or weight of the microbial cells that must be heated. Heating speeds that exceed 2.0 ° C or are equal to 2.5 ° C / minute are thus within the invention. Particularly high heating speeds can be achieved by using special equipment. This can reach a high temperature in a short period of time and thus any oxidation or damage of the PUFA or microbial oil that can be subsequently isolated can be minimized. Thus, the heating must be carried out up to a maximum temperature of up to 140, 150 or equal to 160 ° C. Preferably, the heating can reach a temperature range within 100 to 180 ° C, such as 120 to 160 ° C, preferably 130 to 150 ° C. These temperatures can be achieved quickly using fast heaters, for example, within less than one minute (30 seconds). Each temperature can be reached within 20, 30, 40 or 50 seconds, or it can rise to 150, 175, 200, 225 or 250 seconds. However, each temperature can be reached in small times such as 2, 4, 6, 8 or 10 seconds, using, for example, infusion heaters or relatively small samples. Thus, heating speeds up to 50, 100, 150 or even 200 ° C per minute are achieved. Thus slightly lower heating rates of 5 or 10 at 50 or 60 ° C per minute are possible, as well as from 15 to 45 ° C per minute. This rapid heating during rapid pasteurization has to be found not only to be more effective and require less energy, but to be at least one factor responsible for obtaining a better quality microbial oil (once extracted from the cells after the pasteurization).
Second Aspect- Pasteurization Protocol in Three Stages The first stage can be a warm-up stage. In effect this corresponds to the rapid heating described in the first aspect of the invention and in this way, all the features and characteristics of the first aspect are applied mutatis mutandis to the first stage of the second aspect. The second stage corresponds to the cells when they are on a plateau (temperature). The cells can be stored at a particular and desired temperature (more or less 1 or 2, or equal to 10 ° C) for the desired time. The cells can thus be maintained at a constant temperature. In the plateau stage this temperature (or range of temperatures) is preferably the maximum temperature reached during the pasteurization protocol. The temperature of the plateau stage (and / or the maximum temperature during pasteurization) is preferably at least 70 ° C. It can be less than 90 or 100 ° C, more convenient from 70 to 85 ° C, as well as from 70 to 77 ° C. Alternatively, it can be between 80-160 ° C, as well as, between 100-140 ° C. The length of time of the plateau stage, or the desired one at which the cells are conserved, or at the maximum temperature, should be from 5 seconds to 90 minutes, as well as from 10 to 80 minutes, for example, from 20 up to 70 minutes. This time is optimal from 40 or 50 to 60 or 70 minutes, as well as, from 45 to 65 minutes and more advantageous from 55 to 63 minutes. Also particularly short times are possible, for e. from 8 seconds to 5 minutes. The third stage is a cooling stage. Preferably, the cells are cooled to a temperature that is the same, or is within the ranges mentioned at the beginning of the heating (or first stage). Preferably, the microbial cells are heated and / or cooled linearly (in the first and / or in the third stage, according to convenience), this is so that the cooling or heating profiles appear (approximately) as a straight line when plotting Time versus temperature. The cells can be kept cold, or they can be actively cooled, for example using a heat exchanger and / or a cooling substance, for example, at room temperature (lowering it), or at room temperature, or lower. Preferably the cooling rate is at least 0.4; 0.6; 1.0 or 1.5 ° C / minute. These values represent cooling rates achieved when the cells are allowed to cool on their own. However, faster cooling speeds are possible if a coolant is used. Thus, cooling speeds of at least 2.0; 2.5; 3.0 or up to 3.5 ° C / minute are accessible. However, higher cooling rates are possible, such as below 5 ° C per minute, eg. from 7 or 10 to 50 or 60 ° C per minute, preferably from 15 to 45 ° C per minute. The preferred heating and / or cooling rates are maintained at least at 10, 20 or 30 ° C, although in some embodiments these can be achieved in a range of at least 40 or 50 ° C. It could be recognized that a rapid heating stage and a rapid cooling stage can reduce the amount of energy used in pasteurization. This result not only can achieve lower costs, but also may not adversely affect the quality (of the eventual) microbial oil, in effect, it seems to have beneficial effects on the oil. Third Aspect-Area. Below the Time versus Temperature Graph (Energy Delivery) From the second aspect, it will be evident that, if with the protocol of the invention a time versus temperature graph is plotted, a trapezoidal figure is obtained. The first (heating) and the third stages (cooling) can each form a triangular shape, while the middle or second stage (plateau) (the object of the fourth aspect) is (usually) rectangular. The area below the time versus temperature graph represents the amount of energy consumed in the system. By dividing the pasteurization protocol into three parts, you can calculate the area of the graph, and thus the energy consumed. In the third aspect, the area below the graph of time (in minutes) versus temperature (in ° C) is less than 13,000 ° C. minute. However, lower amounts can be achieved than this and values below 11,000; 10,000; 9,000; 8,000 or equal to 1,000 ° C. minute. In preferred aspects of this invention, these values may be no greater than 7,000; 6,000 or 800 ° C. minute. In the referred chart, time is represented on the x axis (or horizontal axis or abscissa) and 0 ° C represents the origin. The temperature can be plotted on the y axis (or vertical or ordered axis) and 0 ° C represents the origin. Once the cells have been heated to their pasteurization temperature, they can then be cooled (or cooled). The cells are usually cooled to room temperature or room temperature, or at least to a temperature below 30 ° C. There is therefore a time not only for the cells to warm from 30 to 60 ° C, but also a time for the cells to cool from 60 ° C down to 30 ° C. These two times can be summarized to provide a Combined heating and cooling time of 30-60 at 30 ° C. Preferably, this combination is only less than 150 minutes, such as less than 120 or 100 minutes. However, with smaller samples longer times can be achieved and the combined time (30 to 60 and lower to 30 ° C) can be less than 70, 50 or equal to 30 minutes. Fifth Aspect- Pasteurization Protocol with Plateau Stage This protocol can be in accordance with the second aspect, where there is (eg first) a heating stage and (eg second) a cooling stage, in the middle (eg second or middle or intermediate) a plateau stage. However, it is not essential and other pasteurization protocols can be contemplated. The fourth aspect relates preferred features of this stage of the plateau. All the features and characteristics of the second (and other) aspect are applied mutatis mutandis to this fourth aspect. The cells are maintained or left at a particular desired temperature (more or less 1, 2, 5 or equal to 10 ° C) at a temperature (T, ° C) for a time (t, minutes). These two parameters can multiply together giving the product tT. This is convenient from 140 or 280 to 50,000 or 100,800 ° C. minute. Preferably this product is from 500, 1,000, 2,000 or 3,000 or equal to 6,000 to 10,000, 18,000 or 25,000 ° C. minute Optimally, the product tT is from 2,000 to 6,000, as well as, from 3,000 to 5,000, optimally from 4,000 to 4,500 ° C. minute. In some embodiments, the product tT is from 13 to 900, as well as from 100 or 200 to 700 or 800, optimally from 300 to 400 to 600 or 700 ° C. minute. Thus in a manner similar to the third aspect, you may realize that the product tT represents the area under the graph of time versus temperature of the cells when kept at an elevated temperature. Thus, the multiplying factor tT is, in effect, the area under the graph during the plateau stage (but not during the heating or cooling stages). Extraction of a PUFA A fifth aspect of the present invention relates to a process for obtaining a PUFA from microbial cells, the process comprises the pasteurization of the cells according to any (first, second, third or fourth) of the aspects of the invention, as previously described, and extracting and / or isolating a PUFA from the pasteurized cells. A sixth aspect of the present invention relates to a microbial oil which may contain at least 40% arachidonic acid (AA) and / or may have a triglyceride content of at least 90%. The oil may have a POV less than 2.5; 1.5; 0.8; 0.6 or equal to 0.5 and / or an AnV less than 1.0. The oil is prepared by the process of the fifth aspect. Polyunsaturated fatty acids (PUFAs) and microbial oils The PUFA can be a simple PUFA or two or more different PUFAs. The or each PUFA can be of the n-3 or n-6 family. Preferably it is a C18, C20 or C22 PUFA. It can be a PUFA with at least 18 carbon atoms and / or at least 3 or 4 double bonds. The PUFA can be provided in the form of a free fatty acid, a salt, as a fatty acid ester (eg methyl or ethyl ester), as a phospholipid and / or in the form of a mono-, di- or triglyceride. Convenient PUFAs (n-3 and n-6) include: docosahexaenoic acid (DHA, 22: 6 n-3) available in algae or fungi such as Crythecodinium
(dinoflagellate) or the Thraustochytrium (fungus); y-linolenic acid (GLA, 18: 3 n-6); a-linolenic acid (ALA, 18: 3 n-3); Conjugated linoleic acid (octadecadienoic acid,
CLA); dihomo- acid? -linoleic (DGLA, 20: 3 n-6); arachidonic acid (AA, 20: 4 n-6) eicosapentaenoic acid (???, 20: 5 n-3).
Preferred PUFAs include arachidonic acid (??), docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and / or? -linoleic acid (GLA). In particular, the preferred one is AA. The PUFA can be produced by the pasteurized cells in the process of the invention, such as a microbial cell. They can be bacterial cells, algae, fungi or yeast. Fungi are preferred, especially of the order Mocorales, for example, Mortierella, Phycomyces, Blakeslea, Aspercillus, Thraustochytrium, Pythium, or Entomophthora. The preferred source of AA is Morteriella alpina,, Blakeslea trispora, Aspergillus terreus and Pythium insidiosum. The algae can be dinoflagellate and / or even Porphyridium, Nitszchia, or Crypthecodinium (eg Crypthecodiniurn chonií). Yeasts include those of the genus Pichia or Saccharomyces such as Pichia ciferii. The bacteria can be of the genus Propionibacterium. The microbial oil can be liquid (at room temperature). It is preferred that most PUFAs are in the form of triglycerides. Thus, it is preferred that at least 50%, such as at least 60% or optimally at least 70% of the PUFAs are as triglycerides. However, the amount of triglycerides in the oil can be greater, at least 85%, preferably at least 90%, optimally at least 95 or 98%. In these triglycerides preferably at least 40%, such as at least 50% and optimally at least 60% of the PUFAs are in the a position of the glycerol (present in the triglyceride backbone) known as position 1 or 3. Preferred that at least 20%, such as at least 30%, optimally at least 40% of the PUFAs are in position ß (2). The microbial oil may comprise at least 10, 35, 40 or 45% or more of a desired PUFA such as arachidonic acid. It can contain at least 90% triglycerides. Preferably the microbial oils have a triglyceride content of 90 to 100%, at least 96%, preferably at least 98%, more preferably at least 99% and optimally above 99.5%. The microbial oils will typically contain an amount of eicosapentaenoic acid (EPA) of less than 5%, preferably less than 1% and more preferably less than 0.5%. The oil may have less than 5%, less than 2%, less than 1% of each of the PUFAs of C20, C2o-. 3, C22: or? / C20:. The content of free fatty acids (FFA) must be less than or equal to 0.4; 0.2 or 0.1. The oil may or may not have GLA and / or DGLA. The microbial oil can be a crude oil. It can be extracted from the cells using a solvent such as supercritical carbon dioxide, hexane or isopropanol.
Pasteurization process Pasteurization generally takes place after the fermentation has finished. In a preferred embodiment, pasteurization can end with fermentation because heating during pasteurization will kill the cells. Pasteurization, therefore, can be carried out in the fermentation broth (or the cells in an aqueous medium), although it can be carried out in the microbial biomass obtained from both. In the first case, the pasteurization takes place while the microbial cells are still in the thermenter. Preferably the pasteurization takes place before any further processing of the microbial cells, for example, granulation (eg extrusion) comminuted or kneaded. Preferably the pasteurization protocol is sufficient to inhibit or inactivate one or more enzymes, for example, a lipase, which can adversely affect or degrade a PUFA or a microbial oil. Once the fermentation has finished, the fermentation broth can be filtered, or on the other hand, treated to remove the water or the aqueous liquid. After removing the water, a "cake" of biomass can be obtained. If the pasteurization was not performed, then the drained cells (or biomass cake) can be pasteurized.
Process for Removing PUFAs PUFAs (or the microbial oil that usually contains PUFAs) can be extracted from microbial (pasteurized) cells. Preferably, they are extracted from the granules (eg, dried) that contain the cells (eg extruded). The extraction can be done using a solvent. Preferably a non-polar solvent is used, for example an alkane C, preferably a C 2 -alkane, for example, hexane. Carbon dioxide can also be used (in liquid form, for example in the supercritical state). Preferably, the solvent is allowed to filter on the dried granules. In WO-A-97/37032, suitable techniques for granulation and extrusion of microorganisms and subsequent extraction of microbial PUFAs contained in the oil are described. The solvent allows obtaining an oil containing crude PUFAs. This oil can be used in this state, without further processing, or it can be subjected to one or more refining steps. However, a crude oil is generally one that contains a solvent, such as that used to extract oil (eg hexane or an alcohol such as isopropanol) or that has not been subjected to one (or preferably none) of the following steps of refinement. In the applications of International Patent No. PCT / EP01 / 08902 appropriate refining protocols are described (the contents of this document and that of all others described herein are incorporated by reference). For example, the oil may be subjected to one or more of the refining steps, which may include acid treatment or degumming, alkali treatment or removal of free fatty acids, bleaching or pigment removal, filtration, winterization (or cooling, for example to eliminate saturated triglycerides), deodorization (or elimination of free fatty acids) and / or polishing (or elimination of insoluble substances in oil). All of these refining steps are described in great detail in PCT / EP01 / 08902 and muta isis mutandis can be applied in the steps described in the present invention. The resulting oil is particularly suitable for nutritional purposes and can be added to food (human) or food (animal). Examples include milk, formulas for infants, healthy drinks, bread and animal feed. Microbial cells The microbial cells (or microorganisms) used in the present invention can be any of those described above especially in the PUFAs and microbial oils section. They must comprise, or be capable of producing, a PUFA or a microbial oil and suitable for the extraction or isolation of the PUFA oil from the cells. They can be filamentous forms, such as fungi and bacteria, or simple cells such as yeasts, algae and fungi. The cells can comprise microorganisms that are yeasts, algae and bacteria. The preferred fungi are of the order Mucorales for example, the fungus can be of genus Mortierella, Phycomyces, Blakeslea or Aspergillus. Fungi of the species Morteriella alpina, Blakeslea trispora and Aspergillus terreus are preferred. With respect to yeasts they are preferably of the genus Pichia (such as the species Pichia ciferrii) or Saecharomyees. The bacteria can be of the genus Propionibacterium. If the cells come from algae, a dinoflagellate is preferred and / or it belongs to the genus Crypthecodinium. Algae of the species Crypthecodinium cohnii are preferred. Heating This can be done by heating (of the cells) directly or indirectly. If the heating is direct, it can be done by vapor passage inside the fermenter. An indirect method can use a medium as heat exchangers, either through the wall of the fermenter or through heating coils or an external heat exchanger such as a heating plate. Generally, pasteurization takes place in the fermenter vessel where fermentation occurs. Nevertheless, for some organisms (such as bacteria) it is preferred to first remove the cells from the container and then pasteurize. Pasteurization takes place before other processing of organisms, for example, drying or granulation. Pasteurization will usually kill most, or all microorganisms. After pasteurization at least 95%, 96% or up to 98% of the microorganisms have to be dead, that is, they are not alive. Acidification In some cases it is desired to reduce the risk of growth of the pasteurized cells. One possibility is to acidify the cells with an appropriate acid. Thus, in order to prevent the growth of external bacterial species, adjustment of the pH of the cells in a range of 3 to 4 may be desired. However, a wide pH range may be employed depending on the cell, and thus the pH may be Adjust from 2 to 5, optimally to a range of approximately 3.3 to 3.7.
The acidification of the cells can be carried out before pasteurization. However, it is preferable to do it later. The pH can be adjusted by any appropriate means or with any suitable acid. Preferably it is carried out using phosphoric acid, such as 85% or phosphoric acid diluted 55% or 33%. peroxide index (POV) Preferably the POV of a microbial oil is from 4 to 8 or 12, especially for crude oils. However, the POV could be no higher than 3.0; 2.5 or 2.0. However, lower values of POV can be obtained using the process of the invention, and those values can be less than 1.5 or less than 1.0. POV values less than 0.8 or 0.6 and less than 0.4 can be obtained. The values (in the realizations) are within a range of 1.3 (or 0.8) to 0.4. The unit (for POV) is usually meq / kg. anisidine index (AnV) This value can give a measure of the aldehyde content. Preferably the anisidine number of a microbial oil is from 5, 6, 7 or 10 to 15, 20 or 25, especially for a crude oil. The appropriate AnV is no more than 20, for example no more than 15. It can be no more than 10 or no more than 5. Preferably the POV and / or AnV values refer to crude oils rather than refined oils. The values of AnV (in preferred experiments) are within a range of 15 to 5, optionally 12 to 7. Crude versus refined oils The following are some differences between these two oils. Each crude or refined oil may have one or more traces of the following Table for crude or refined oils. A crude oil will usually contain an antioxidant (eg, tocopherol, ascorbyl palmitate).
Preferred Substance Crude oil Refined oil (for crude) Insaparable < 3.5% (w / w) 2.5% (w / w) 1.8% (w / w) Solvent (ex. Exano) < 2000 ppm 100-2000 ppm Not detectable or < lppm
Phospholipids% 2-3.5 0.05 Free fatty acids, < 1% 0.20% 0.08% as oleic POV < 10 meq / kg 6 meq / kg 1.4 meq / kg Not soluble < 0.5% 0.10% Phosphorous < 1000 mg / kg 5 mg / kg Silicones < 500 ppm 100 ppm 2 ppm Arsenic < 0.5 mg / kg < 0.04 mg / kg < 0.5 mg / kg Cadmium < 0.2 mg / kg < 0.02 mg / kg < 0.1 mg / kg Mercury < 0.04 mg / kg < 0.4 mg / kg < 0.0 mg / kg (continued)
Conveniently, the crude oil in the present invention may have one or more of the following features: (a) a content of unsaponifiables from 2.0 to 3.5% (W / W); (b) a solvent content (eg, hexane) of 10, 50 or 100 ppm at 1,000, 1,500 or 2,000 ppm; (c) a content of free fatty acids from 0.1 or 2.0% to 1.0%, eg.0.2-0.6 or 0.3-0.5%; (d) a POV value from 2,3,4 or 6 to 10; (e) a phosphorus content of at least 2.3 or 5 mg / kg;
(f) a silicone content of 50 or 100 ppm; I
(g) a water content less than 1% or from 0.5 to 1 or 2%. Uses of oils and PUFAs A sixth aspect of the invention relates to a composition containing the oil of the fifth aspect and where there is an appropriate or more (additional) substances.
The composition may be an edible and / or a food supplement for animals or humans. In embodiments of the invention that are for human consumption the oils may become suitable for human consumption, typically by refining or purifying the oil obtained from the microbes. The composition can be a formula for infants or edible (human). In this case, the composition of the formula must be adjusted so that it has a quantity of lipids or PUFAs similar to breast milk.
This may involve mixing the microbial oil of the invention with other oils in order to achieve an appropriate composition. The composition can be a food composition or animal or marine supplement. Each food or supplement can be obtained from any farm animal, in particular sheep, cattle and poultry. In addition, food or supplements can be obtained from marine organisms such as fish and molluscs. The composition can thus include one or more food substances or ingredients of each animal. The oil of the invention can be sold directly as oil and contained in an appropriate container, generally an aluminum container covered in its interior by an epoxyphenolic lacquer and gassed with nitrogen. The oil may contain one or more antioxidants (eg, tocopherol, vitamin E, palmitate) each, for example, at a concentration of 50 to 800 ppm, such as 100 to 700 ppm. Appropriate compositions may include pharmaceutical and veterinary compositions, e.g. oral administration or cosmetic compositions. The oil may be administered as such or may be encapsulated, for example in a shell and may thus be in the form of a capsule. The caps or capsules may contain gelatin and / or glycerol. The composition may contain other ingredients, for example flavorings (eg lemon or lime flavor) or a vehicle or excipient accepted in pharmaceutical and veterinary. The features and characteristics of one aspect of the invention are applicable rnutatis mutandis to another aspect. The invention will be described by way of examples with reference to the following Examples, which are provided by means of illustrations and are not intended to limit the scope. Example 1 Oxidation during the production of a microbial oil containing PUFAs is caused by enzymatic activity. . Pasteurization is considered as a method of stabilizing oxidation during the processing of microbial cells to obtain an oil. The extent of the stabilization was found to depend on the conditions of the pasteurization. A number of experiments were conducted to determine which pasteurization conditions may affect the oxidation levels and, in particular, the peroxide value (POV) of the oil. The peroxide indices were determined using the standard protocol detailed in AOCS: Cd8-53. The experiments follow the following protocol: fermentation; storage; pasteurization; extraction (microbial oil); oil analysis. The fungus Mortierella alpina was cultivated in a termendor. The fermentation takes approximately 148 hours. M. Alpina produces the PUFA called arachidonic acid (AA). The biomass was removed from the fermenter and stored (at a temperature below -18 ° C). Samples of the biomass of M. Alpina were removed from the fermentation broth when they were still inside the fermenter and immediately frozen. Several pasteurization protocols were tested. The pasteurization was carried out at three different temperatures, namely 40, 70 and 85 ° C. The protocol followed a process in three stages, with a first stage of rapid heating followed by a plateau (a second or a half stage) at a temperature desired which is the maximum temperature used. Continues a stage (third) of rapid cooling. Different samples of the biomass are subjected to an average stage (plateau) of three different temperatures, namely one, two and 24 hours.
After pasteurization, the microbial oil is obtained using a wet extraction technique. This sample of biomass was filtered, squeezed (under pressure) and the oil extracted. The microbial oil is then analyzed, above all for the peroxide index (POV) using an AOCS method. The AA content of some samples was determined. The analyzes showed that the obtained microbial oil had approximately 420 g of AA per kg. Detailed Protocol: Fermentation and Extraction of Samples. One liter of the fermentation broth was removed from the fermenter vessel and filtered (Seitz two-liter filter, F-FA10). The resulting cake was then washed with 600 ml of distilled water. The wet cake is dried by airflow for one minute and then pressed (using a HAFICO ™ apparatus, dyeing press, C-0A021, 300-400 atm) at 400 bar. The wet extrudate was then used to extract a microbial oil with 500 ml of hexane (Merck) at room temperature (20 to 25 ° C) for one hour using Ultra Turrax ™ equipment. The hexane was then decanted. The remaining cake was then washed with 250 ml of fresh hexane (with stirring for 30 minutes) at room temperature. The hexane was decanted and added to the previous hexane extract. The extract was then filtered using a glass filter in combination with a GFA glass filter. The hexane was then evaporated from the clear extract at 50 ° C for approximately 15 minutes using a Rotavapor ™ equipment. The oil was then transferred to sealed containers and each sample was then gassed with nitrogen for 30 seconds. The sample was then closed and stored at -18 ° C. Pasteurization Protocols Three different protocols were tested (A, B and C). Each one consists of three stages, a first stage of heating, a second stage plateau (at a maximum temperature) and a third stage of cooling. Next, Table 1 shows the protocols of the three pasteurization profiles.
t o
Time Temp Stage Change Time Area Speed Time Times Low Area
Table 1 (t, min.) (T, ° C) at temp in per stage under Cal / Enf to pass Comb 40- graf. t vs. Time (t) stage (° C) (min) of the profile (° C / min) of 40-70 ° C 70-40 ° C T (° C.min) (min) (min) ("C.min)
Profile A 0 25 75 70 heat 45 t heat = 75 1687.5 0.6 50 7575 135 70 pasteur. 0 t past = 60 4200 0 210 25 cold 45 t cold = 65 1687.5 0.6 50 100 Profile B 0 25 (out of 102 72 heat 48 t heat = 102 4896 0.46 65.11 13968 inv for 162 72 pasteur. = 60 4320 0 comp) 360 28 cold 48 t cold = 198 4752 0.22 135 200.11 Profile C 0 7 25 70 heat 63 t heat = 25 787.5 2.52 11.9 5607.5 85 70 pasteur. 0 t past = 60 4200 0 105 8 cold 62 t cold = 20 620 3.1 9, -8 21.58
The three pasteurization profiles A, B and C are also shown in Figure 1. It can be seen that the area under the curve of the temperature graph (T °, C) versus time (t, minutes) can be calculated for each of the three steps of each profile and then add them to calculate the area under the graph for each of the three profiles. These calculations are also shown in the previous Table 1. The peroxide index (POV) was determined for the oils that resulted from the extraction of the cells followed by the three pasteurization protocols A, B and C.
The POV of the extracted oil were 8.7; 14.3 and 2.4; respectively. Profile B had a slow heating rate and a slow cooling speed and is presented for comparison only. He has the greatest
POV of 14.3. In contrast, profiles A and C are both within the invention. Profile A has faster heating and cooling speeds in the first and third stages than profile B. Preferably, in the invention the heating and cooling rates are at least as fast as those shown in profile A. Profile A has a POV of 8.7. However, the best results were obtained using profile C, which had a POV of only 2.4. As can be seen in Figure 1, this had a very rapid heating stage and a rapid (third) cooling stage. Example 2 Experiments similar to Example 1 were carried out except that in this case the pasteurization temperature was modified more broadly, namely at 40 ° C (for comparison), 70 ° C and 85 ° C. The temperature profile (° C) vs. time (minutes) is shown in Figure 2 and Table 2. The profile was essentially the same for all samples, but of course with an appropriate extension of the pasteurization plateau (from one hour to 4 or 24 hours). Table 2
Table 2 (continued)
Samples from two different fermentations (both from M. Alpina) were analyzed. Samples Nos. 11 to 20. Table 3 has a slightly longer fermentation where approximately 2m3 of broth was transferred to an inoculant fermenter and the fermentation was extended for 48 hours without any future added glucose. After pasteurization, the samples were processed starting with a pressure filtration of approximately 1 bar of nitrogen. The resulting cake was then washed with distilled water (approximately 0.6 of the initial volume of broth). The water was removed using a press with a piston at a pressure of 300 to 400 bar. Then, 500 ml of fresh hexane was added and mixed using Ultra-turrax equipment for one minute. The extraction takes place for about one hour at room temperature. After filtration, the resulting cake was washed with 250 ml of fresh hexane and the resulting solvent was evaporated under vacuum from 60 ° C to 70 ° C. Then he gassed with nitrogen and kept at -18 ° C. The results are shown in Table 3, which includes a first and a second measurement of the peroxide value and an average of these two values, as well as the anisidine indexes (AnV). The reduction of POV and AnV are also shown in Figures 3 and 4 (for shorter and longer fermentations, respectively). Table 3
Table 3. (continued)
From the results it can be seen that without pasteurization the POV was 5.6 or 5.7. Pasteurization at 40 ° C may reduce the POV, but relatively longer times (such as 24 hours) at the pasteurization temperature are required in order to reduce the POV to an acceptable value of 2.1. The highest temperatures are considered the most successful. For example, pasteurization for only 1 hour at 70 ° C gives a POV of 2.2 when compared to a POV of 2.1 for 24 hours at 40 ° C. The best values were obtained at the highest temperatures, with 85 ° C for 1 hour giving a POV value of only 1.2. (These figures are cited for shorter fermentations, although similar results may be found with cells growing in longer fermentations). Figures 3 and 4 thus show graphically how the values of POV and AnV change with respect to the different pasteurization times. As expected, the longer pasteurization times give the lowest values of POV and AnV. However, the use of relatively high temperatures during pasteurization is of more importance. A marked decrease in AnV and POV was found when the pasteurization temperature (Tpast) was increased to 70 ° C, and even lower values were found at 85 ° C. (The three upper lines indicated with crosses, full circles and asterisks show the values of AnV, while the three lower lines indicated with diamonds, squares and triangles give the values of POV). Table 4 shows the calculated product tT (in ° C minute) for nine different pasteurization protocols (three different plateau temperatures and for three different times). In effect, this product represents the area under the graph (time, t, minutes vs. temperature, T, ° C) for the plateau stage (after the heating stage, but before the cooling stage).
Table 4
EXAMPLE 3 Future pasteurization tests were performed using fermentation broths following large scale production fermentations using the M. alpina fungus, as exemplified above. An unpasteurized broth (800 liters) was transported and stored at 4 ° C. The broth was then transferred to a 700 liter vessel with agitation and 10 different pasteurization protocols were performed. First, pasteurization was carried out at five different (maximum) temperatures, namely 140, 120, 100, 80 and 60 ° C in a permanent time (plateau) for 8 seconds (at maximum temperature). Second, pasteurization was performed at 140, 120, 100, 80 and 60 ° C at a permanent time (plateau) at maximum temperature for 300 seconds.
Samples were taken (2 liters) and directly frozen at -18 ° C. Sterile samples (200 ml) were taken and frozen, and the crude AA oil was recovered from the samples using the following protocol. A sample of the fermentation broth (1.7 liters) was filtered at 1 bar of N2. The cake was washed with 0.6 volumes of distilled water and squeezed for approximately 5 minutes at 400 kg / cm2. Then, n-hexane was added to the wet cake and crumbled using Ultra Turrax equipment at 24,000 rpm. The oil was extracted at room temperature (approximately 21 ° C) for approximately 110 minutes. The suspension was vacuum filtered using a GF / A Whatman media filter. The cake was washed with 250 ml of fresh hexane. The hexane was evaporated for 15 minutes in a water bath at a temperature of about 60 to 70 ° C. The resulting oil was then transferred to an airtight container, which was gassed with nitrogen for 30 seconds and then closed and stored at -18 ° C before being analyzed. Figures 5, 6 and 7 provide the following data for analysis. Figures 6 and 7 show the time profiles as a function of temperature for the two sets of experiments, the first with a plateau time (permanence) of 8 seconds, and the second with a plateau time of 5 minutes, each of the 5 set temperatures, respectively. As can be seen from the graph, the horizontal middle line (representing 8 seconds or 5 minutes) shows the plateau stage. Figure 5 shows the values of POV and AnV that result from all 10 pasteurization regimes. As can be seen, the lowest values of POV were obtained with the increase of the high temperatures and the longer residence time (5 minutes) provides the lowest value of POV.
Claims (4)
1. A process for pasteurizing microbial cells, characterized in that the process comprises heating the cells at a temperature comprised from 40 ° C to 70 ° C and not more than 30 minutes or at a speed greater than 0.5 ° C / minute.
2. A process for pasteurizing microbial cells characterized in that it comprises three stages, namely a heating stage (first), a (second) plateau stage (in which the cells are kept at a constant temperature) and a cooling stage (third).
3. A process for pasteurizing microbial cells, characterized in that the process comprises heating the cells using a pasteurization protocol such that the area below the graph of time (minutes) versus temperature (° C) is less than 13,000 ° C. minute.
4. A process for pasteurizing microbial cells, the process characterized in that it comprises heating the cells and maintaining the cells at an elevated temperature (T, ° C) for a time (t, minutes) in a plateau stage where the product tT is from 140 to 100,800 ° C. minute. A process according to claim 2 or 4 characterized in that: (a) the plateau is the maximum temperature; (b) the shape of the graph of the pasteurization protocol of time (t) vs temperature (T) is a trapezoid; (c) heating and / or cooling is linear; and / or (d) the cells are heated from an initial temperature below 40 ° C and / or heated to a temperature above 70 ° C; (e) the cells contain, or produce, a PUFA or a microbial oil (which optionally contains PUFA). A process according to any of the preceding claims characterized in that the microbial cells are heated from 40 ° C to 70 ° C in no more than 15 minutes and / or the cells are heated at a speed of at least 0.6 or 1.0 ° C / minute A process according to any of the preceding claims characterized in that: (a) the microbial cells are heated at a rate of at least 2 ° C / minute; (b) the pasteurization temperature (plateau) is from 70 to 100 ° C, optimally from 70 to 85 ° C; (c) the cells are cooled at a rate of at least -0.6 or -1.6 ° C / minute, and / or (d) the area below the graph time (minute) versus temperature (° C) is less than 10,000 or 8,000 ° C. minute. A process for obtaining a PUFA or microbial cell microbial oil, the process characterized in that it comprises the pasteurization of the cells according to any of the preceding claims and the extraction or isolation of a PUFA or a microbial oil from the pasteurized cells . A microbial oil having a triguceride content of at least 90%, a peroxide index (POV) of less than 1.5 (or 1.0) and / or an anisidine index (AnV) less than 15, optionally less than 12. An oil according to claim 9 characterized in that: (a) the PUFA contains a fatty acid? -3 or (b) the PUFA content is at least 40%; (c) the PUFA contains arachidonic acid (AA), eicosapentaenoic acid (EPA) and / or docosahexaenoic acid (DHA), and / or (d) the oil is crude or unrefined.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02254262 | 2002-06-19 | ||
EP02258713 | 2002-12-18 | ||
PCT/EP2003/006553 WO2004001021A1 (en) | 2002-06-19 | 2003-06-20 | Pasteurisation process for microbial cells and microbial oil |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04012913A true MXPA04012913A (en) | 2005-03-31 |
Family
ID=30001870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04012913A MXPA04012913A (en) | 2002-06-19 | 2003-06-20 | Pasteurisation process for microbial cells and microbial oil. |
Country Status (17)
Country | Link |
---|---|
US (7) | US7517953B2 (en) |
EP (10) | EP1513922B2 (en) |
JP (7) | JP2005529621A (en) |
KR (7) | KR20180081845A (en) |
CN (11) | CN109010853A (en) |
AT (1) | ATE419330T1 (en) |
AU (1) | AU2003245978A1 (en) |
BR (1) | BRPI0311906B1 (en) |
CA (2) | CA3030068C (en) |
DE (1) | DE60325590D1 (en) |
DK (2) | DK1513922T4 (en) |
EA (2) | EA015509B1 (en) |
ES (2) | ES2320645T5 (en) |
HK (2) | HK1203856A1 (en) |
IL (2) | IL165530A (en) |
MX (1) | MXPA04012913A (en) |
WO (1) | WO2004001021A1 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2295594B1 (en) | 2000-01-19 | 2018-04-04 | DSM IP Assets B.V. | Solventless extraction process |
KR20180081845A (en) * | 2002-06-19 | 2018-07-17 | 디에스엠 아이피 어셋츠 비.브이. | Pasteurisation process for microbial cells and microbial oil |
DK2337459T3 (en) * | 2008-08-29 | 2013-01-21 | Fructa & Co S R L | Process for preparing a package for vegetable or fruit meat or mash |
DE102009003147A1 (en) | 2009-05-15 | 2010-11-18 | Zf Lenksysteme Gmbh | Method for operating a steering system in a vehicle |
CN102597242B (en) * | 2009-06-08 | 2016-03-02 | 罗特哈姆斯泰德研究有限公司 | New fats acid extends composition and use thereof |
US8399226B2 (en) * | 2009-06-16 | 2013-03-19 | E I Du Pont De Nemours And Company | High eicosapentaenoic acid oils from improved optimized strains of Yarrowia lipolytica |
JP6476436B2 (en) | 2009-11-03 | 2019-03-06 | ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. | Composition comprising a cell and a polyunsaturated fatty acid (LC-PUFA) having at least 20 carbon atoms |
CN102595937A (en) * | 2009-11-10 | 2012-07-18 | 巴斯夫欧洲公司 | Health-beneficial preparation and production method |
EP2576801B1 (en) | 2010-06-01 | 2019-10-02 | DSM IP Assets B.V. | Extraction of lipid from cells and products therefrom |
CN102589145A (en) * | 2012-03-27 | 2012-07-18 | 鲁东大学 | Electric water heater circuit with pasteurization function |
EP2826384A1 (en) | 2013-07-16 | 2015-01-21 | Evonik Industries AG | Method for drying biomass |
WO2015095462A1 (en) * | 2013-12-20 | 2015-06-25 | BP Biofuels UK Limited | Process for extracting lipids for use in production of biofuels |
MX2016008223A (en) | 2013-12-20 | 2016-11-28 | Dsm Ip Assets Bv | Processes for obtaining microbial oil from microbial cells. |
WO2015095690A2 (en) | 2013-12-20 | 2015-06-25 | Dsm Ip Assets B.V. | Processes for obtaining microbial oil from microbial cells |
PL3082793T3 (en) | 2013-12-20 | 2020-10-05 | Dsm Ip Assets B.V. | Processes for obtaining microbial oil from microbial cells |
BR112016014516B1 (en) | 2013-12-20 | 2022-02-22 | Dsm Ip Assets B.V | PROCESSES TO OBTAIN MICROBIAL OIL FROM MICROBIAL CELLS AND OIL |
CN105925627B (en) * | 2014-03-14 | 2019-08-13 | 嘉必优生物技术(武汉)股份有限公司 | Microbial oil and preparation method thereof |
CN105713936B (en) * | 2014-03-14 | 2019-05-10 | 嘉必优生物技术(武汉)股份有限公司 | The preparation method of microbial oil |
ES2873094T3 (en) | 2014-10-02 | 2021-11-03 | Evonik Operations Gmbh | Procedure for the production of a feed containing PUFAs by extrusion of a biomass containing PUFAs of the Labyrinthulomycetes type |
WO2016050552A1 (en) | 2014-10-02 | 2016-04-07 | Evonik Degussa Gmbh | Process for producing a pufa-containing biomass which has high cell stability |
BR112017006833B1 (en) | 2014-10-02 | 2022-09-13 | Evonik Operations Gmbh | FOOD FOR ANIMALS CONTAINING POLY-UNSATURATED FATTY ACID AND A PROCESS TO PRODUCE THE SAME |
BR112017005388B1 (en) | 2014-10-02 | 2022-09-13 | Evonik Operations Gmbh | FOOD FOR ANIMALS CONTAINING AURANTIOCHYTRIUM BIOMASS |
EP3341457A4 (en) * | 2015-08-25 | 2019-05-01 | DSM IP Assets B.V. | Refined oil compositions and methods for making |
JP6998935B2 (en) | 2016-07-13 | 2022-01-18 | エボニック オペレーションズ ゲーエムベーハー | How to Separate Lipids from Dissolved Lipid-Containing Biomass |
CA3034122A1 (en) | 2016-08-19 | 2018-02-22 | Noblegen Inc. | Methods and uses of dissolved organic material fractions for binding metal ions |
DK3562925T3 (en) | 2016-12-27 | 2021-05-25 | Evonik Operations Gmbh | PROCEDURE FOR ISOLATING LIPIDES FROM A LIPID-CONTAINING BIOMASS |
JP2020516768A (en) | 2017-04-07 | 2020-06-11 | ノーブルジェン・インコーポレーテッド | Method for binding metals and use of encapsulated exudate and dried euglena biomass |
WO2019032880A1 (en) * | 2017-08-10 | 2019-02-14 | Dsm Ip Assets B.V. | Double centrifugation process for nutritive oil purification |
EP3470502A1 (en) | 2017-10-13 | 2019-04-17 | Evonik Degussa GmbH | Method of separating lipids from a lysed lipids containing biomass |
CN107418982B (en) * | 2017-09-25 | 2020-05-08 | 嘉必优生物技术(武汉)股份有限公司 | Low-chloropropanol microbial oil and preparation method thereof |
EP3527664A1 (en) | 2018-02-15 | 2019-08-21 | Evonik Degussa GmbH | Method of isolating lipids from a lipids containing biomass |
BR112020023222A2 (en) | 2018-05-15 | 2021-03-23 | Evonik Operations Gmbh | method of isolating lipids from a biomass containing lipids lysed by emulsion inversion |
WO2019219443A1 (en) | 2018-05-15 | 2019-11-21 | Evonik Operations Gmbh | Method of isolating lipids from a lipids containing biomass with aid of hydrophobic silica |
CN108753457A (en) * | 2018-08-03 | 2018-11-06 | 梁云 | The method for improving microbial grease stability and safety |
JP2022512618A (en) * | 2018-11-02 | 2022-02-07 | フイルメニツヒ ソシエテ アノニム | Antioxidation of perfume and food ingredients |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE150627C (en) | 1903-05-19 | |||
US3106571A (en) * | 1955-10-14 | 1963-10-08 | Thomas C Fisher | Physico-mechanical process of obtaining high quality cocoanut oil |
US3642958A (en) | 1968-05-14 | 1972-02-15 | Stauffer Chemical Co | Isobutoxy-s-(4-chlorophenyl) ethylphosphonodithioate |
DE1923529A1 (en) | 1968-05-29 | 1969-12-04 | Ingtech Zentralbuero Veb | Purification of fermentation products |
GB1411450A (en) | 1972-12-19 | 1975-10-22 | British Petroleum Co | Process for the purification of a micro-organism product |
GB1466853A (en) | 1973-05-22 | 1977-03-09 | Simon Rosedowns Ltd | Extraction |
US3958027A (en) * | 1974-06-14 | 1976-05-18 | Simon-Rosedowns Limited | Extraction |
US4056638A (en) * | 1975-06-16 | 1977-11-01 | E. I. Du Pont De Nemours And Company | Dielectric drying of fungal material and resultant textured product |
DD150627A1 (en) | 1980-05-07 | 1981-09-09 | Klaus Triems | PROCESS FOR OBTAINING AND SOLVENT EXTRACTION OF SOLIDS |
US4526902A (en) * | 1983-10-24 | 1985-07-02 | Century Laboratories, Inc. | Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions |
DE3470061D1 (en) | 1984-02-09 | 1988-04-28 | Agency Ind Science Techn | A method for the preparation of a fungal body and a lipid rich in gamma-linolenic acid therefrom |
US5411873A (en) * | 1984-05-29 | 1995-05-02 | Genencor, Inc. | Process for producing heterologous polypeptides |
JPS6114607U (en) | 1984-06-29 | 1986-01-28 | 友和産業株式会社 | Press plate for coil end packaging |
IT1180935B (en) | 1984-12-14 | 1987-09-23 | Vittorio Bertoli | VOLUMETRIC PUMP, IN PARTICULAR FOR FLUID FOOD PRODUCTS CONTAINING SOLID PARTS |
JPS6244170A (en) † | 1985-08-19 | 1987-02-26 | Agency Of Ind Science & Technol | Method of extracting mold of genus mortierella with supercritical fluid |
JPH0716424B2 (en) | 1985-10-01 | 1995-03-01 | ライオン株式会社 | Method for producing arachidonic acid-containing lipid |
US4944954A (en) * | 1986-04-23 | 1990-07-31 | Epe Incorporated | Vegetable oil extraction process |
JPH0741767B2 (en) | 1986-07-31 | 1995-05-10 | 株式会社ブリヂストン | Pneumatic radial tires for heavy loads |
JPH0756091B2 (en) | 1986-08-05 | 1995-06-14 | 株式会社豊田自動織機製作所 | Method and device for controlling tail winding yarn in ring spinning machine |
EP0276541B2 (en) | 1987-01-28 | 1998-08-26 | Suntory Limited | Process for production of arachidonic acid |
JPS6438007A (en) | 1987-04-28 | 1989-02-08 | Lion Corp | Skin external preparation |
JP2746371B2 (en) | 1987-12-21 | 1998-05-06 | サントリー株式会社 | Bishomo-γ-linolenic acid and method for producing lipid containing the same |
JPH01207257A (en) | 1988-02-15 | 1989-08-21 | Nippon Oil & Fats Co Ltd | Method for separating alpha-linolenic acid |
JPH0213388A (en) | 1988-06-30 | 1990-01-17 | Lion Corp | Preparation of lipid containing unsaturated fatty acid |
JPH062068B2 (en) | 1988-07-06 | 1994-01-12 | 出光石油化学株式会社 | Method for producing ω6 unsaturated phospholipids containing unsaturated fatty acid |
US5340594A (en) * | 1988-09-07 | 1994-08-23 | Omegatech Inc. | Food product having high concentrations of omega-3 highly unsaturated fatty acids |
US5130242A (en) | 1988-09-07 | 1992-07-14 | Phycotech, Inc. | Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
JPH02142486A (en) | 1988-11-25 | 1990-05-31 | Lion Corp | Production of unsaturated fatty acid-containing lipid |
JP2664452B2 (en) | 1988-12-23 | 1997-10-15 | サントリー株式会社 | Fish and shellfish feed |
US5935828A (en) | 1989-05-01 | 1999-08-10 | Opta Food Ingredients, Inc. | Enzymatic production of monoglycerides containing omega-3 unsaturated fatty acids |
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
US5244921A (en) | 1990-03-21 | 1993-09-14 | Martek Corporation | Eicosapentaenoic acids and methods for their production |
DK95490D0 (en) | 1990-04-18 | 1990-04-18 | Novo Nordisk As | PROCEDURE FOR PREPARING TRIGLYCERIDE AND TRIGLYCERIDE COMPOSITION |
US5658767A (en) * | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
CA2101274C (en) * | 1991-01-24 | 1998-12-15 | David J. Kyle | Microbial oil mixtures and uses thereof |
PH11992043811B1 (en) | 1991-01-24 | 2002-08-22 | Martek Corp | Arachidonic acid and methods for the production and use thereof |
FR2674865A1 (en) | 1991-04-02 | 1992-10-09 | Bioprox Ste Angevine Biotechno | Process for the preparation of a liquid concentrate of lactic acid, concentrate obtained and its use in the food industry |
GB9111900D0 (en) | 1991-06-03 | 1991-07-24 | Efamol Holdings | Fatty acid compositions |
US5112803A (en) † | 1991-06-21 | 1992-05-12 | International Flavors & Fragrances Inc. | Octalactone-containing composition, fermentation process for producing same and organoleptic uses thereof |
DE69210892T2 (en) * | 1991-07-11 | 1996-10-02 | Idemitsu Petrochemical Co | Dry cell fragments containing triglycerides and process for their preparation |
JPH0517796A (en) * | 1991-07-11 | 1993-01-26 | Idemitsu Petrochem Co Ltd | Recovery of triglyceride |
ES2073936T3 (en) † | 1991-11-15 | 1995-08-16 | Hoffmann La Roche | STABILIZATION OF MARINE OILS. |
DE4219360C2 (en) * | 1992-06-12 | 1994-07-28 | Milupa Ag | Process for the production of lipids with a high proportion of long-chain, highly unsaturated fatty acids |
JPH061996A (en) * | 1992-06-17 | 1994-01-11 | Asahi Denka Kogyo Kk | Transesterification of oil and fat |
JPH0663082A (en) * | 1992-08-19 | 1994-03-08 | Tokai Konetsu Kogyo Co Ltd | Treatment of medical treatment waste |
JP3354608B2 (en) | 1992-11-16 | 2002-12-09 | サントリー株式会社 | Method for producing polyunsaturated fatty acid and lipid containing the same |
AU683027B2 (en) | 1993-01-27 | 1997-10-30 | Scotia Holdings Plc | Triglycerides |
JPH0731871A (en) | 1993-05-18 | 1995-02-03 | Canon Inc | Membrane structure |
ATE446101T1 (en) † | 1993-06-09 | 2009-11-15 | Martek Biosciences Corp | USE OF DOCOSAHEXAENIC ACID FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF SENIL DEMENTIA AND ALZHEIMER'S DISEASE |
US5411872A (en) * | 1993-09-08 | 1995-05-02 | Cornell Research Foundation, Inc. | Method for transfected cell selection |
JP2746074B2 (en) | 1993-09-22 | 1998-04-28 | 富士電機株式会社 | Manufacturing method of amorphous silicon solar cell |
JPH07188692A (en) | 1993-12-27 | 1995-07-25 | Ikeda Shiyokuken Kk | Removal of peroxide from composition containing highly unsaturated fatty acid |
JP3071088B2 (en) | 1994-03-02 | 2000-07-31 | 昭和産業株式会社 | Method for producing fats and oils and microorganisms used therefor |
JP3369306B2 (en) | 1994-05-18 | 2003-01-20 | 大日本印刷株式会社 | Apparatus for distributing personal information to a system that issues personal information recording media |
DE69527849T2 (en) * | 1994-10-31 | 2002-12-05 | Morton Coutts Ltd | PASTEURIZATION AND FERMENTATION OF A FERMENTABLE EXTRACT |
CO4750597A1 (en) * | 1995-06-07 | 1999-03-31 | Danisco | METHOD AND COMPOSITION TO IMPROVE THE FLOUR MASS. |
JPH0936492A (en) | 1995-07-24 | 1997-02-07 | Rohm Co Ltd | Semiconductor laser element and fabrication thereof |
US6255505B1 (en) * | 1996-03-28 | 2001-07-03 | Gist-Brocades, B.V. | Microbial polyunsaturated fatty acid containing oil from pasteurised biomass |
CN102304036A (en) † | 1996-03-28 | 2012-01-04 | Dsmip资产有限公司 | The preparation of granular microbial biomass and the separation method of valuable compounds therefrom thereof |
ES2267137T5 (en) | 1996-03-28 | 2014-03-14 | Dsm Ip Assets B.V. | Microbial oil containing polyunsaturated fatty acid and method of producing oil from pasteurized and granulated biomass |
JP3792309B2 (en) † | 1996-08-30 | 2006-07-05 | サントリー株式会社 | Process for producing unsaturated fatty acid-containing fats and oils |
JP4633204B2 (en) † | 1996-10-11 | 2011-02-16 | サントリーホールディングス株式会社 | Arachidonic acid-containing edible oil and fat and food containing the same |
ES2446982T3 (en) † | 1996-12-27 | 2014-03-11 | Suntory Holdings Limited | Means for culturing microorganisms and method for producing unsaturated fatty acids or lipids that contain them |
US6391596B1 (en) † | 1997-09-25 | 2002-05-21 | Cp Kelco U.S., Inc. | High viscosity xanthan and process for preparing same |
KR20010052854A (en) † | 1998-06-17 | 2001-06-25 | 윌리암 로엘프 드 보에르 | Microbial arachidonic acid(ara) for use in marine feed |
JP2000069987A (en) * | 1998-08-28 | 2000-03-07 | Suntory Ltd | Production of arachidonic acid-containing lipid and dihomo-gamma-linolenic acid-containing lipid |
EP0986960A1 (en) * | 1998-09-15 | 2000-03-22 | Dsm N.V. | Mucorales fungi for use in preparation of textured products for foodstuffs |
CN102090636A (en) * | 1998-10-15 | 2011-06-15 | Dsm公司 | PUFA supplements |
NO311041B1 (en) * | 1999-12-22 | 2001-10-01 | Norsk Hydro As | Stabilization of pigments and polyunsaturated oils and oil concentrates |
EP1133926A1 (en) | 2000-03-17 | 2001-09-19 | Dsm N.V. | Foodstuffs containing mucorales fungi |
EP1178118A1 (en) † | 2000-08-02 | 2002-02-06 | Dsm N.V. | Isolation of microbial oils |
EP1178103A1 (en) | 2000-08-02 | 2002-02-06 | Dsm N.V. | Purifying crude pufa oils |
EP2266525B1 (en) | 2002-05-03 | 2012-07-11 | Martek Biosciences Corporation | High quality lipids and methods for producing by enzymatic liberation from biomass |
KR20180081845A (en) * | 2002-06-19 | 2018-07-17 | 디에스엠 아이피 어셋츠 비.브이. | Pasteurisation process for microbial cells and microbial oil |
ES2563649T3 (en) | 2003-12-30 | 2016-03-15 | Dsm Ip Assets B.V. | Deaeration Process |
JP4849806B2 (en) † | 2005-02-08 | 2012-01-11 | 日本水産株式会社 | Method for producing polyunsaturated fatty acids using novel cell treatment method |
FR3005154B1 (en) | 2013-04-26 | 2015-05-15 | Commissariat Energie Atomique | ELECTROMAGNETICALLY INDUCED HEATING FURNACE, USE OF THE OVEN FOR FUSION OF A MIXTURE OF METAL (UX) AND OXIDE (S) REPRESENTATIVE OF A CORIUM |
JP6342925B2 (en) | 2016-02-08 | 2018-06-13 | ファナック株式会社 | Injection molding cell and injection molding cell management system |
-
2003
- 2003-06-20 KR KR1020187019579A patent/KR20180081845A/en active Application Filing
- 2003-06-20 CN CN201811093738.1A patent/CN109010853A/en active Pending
- 2003-06-20 CN CN201010141759A patent/CN101837140A/en active Pending
- 2003-06-20 EA EA200500046A patent/EA015509B1/en not_active IP Right Cessation
- 2003-06-20 CN CN201010141614.3A patent/CN101837136B/en not_active Expired - Lifetime
- 2003-06-20 MX MXPA04012913A patent/MXPA04012913A/en active IP Right Grant
- 2003-06-20 CN CN201410270196.6A patent/CN104138606A/en active Pending
- 2003-06-20 CN CN201010141709.5A patent/CN101837138B/en not_active Expired - Lifetime
- 2003-06-20 CA CA3030068A patent/CA3030068C/en not_active Expired - Lifetime
- 2003-06-20 CN CN201410270273.8A patent/CN104162176A/en active Pending
- 2003-06-20 US US10/518,146 patent/US7517953B2/en not_active Expired - Lifetime
- 2003-06-20 CN CN201010141637.4A patent/CN101837137B/en not_active Expired - Lifetime
- 2003-06-20 KR KR1020117002503A patent/KR101435707B1/en active IP Right Grant
- 2003-06-20 ES ES03738077.1T patent/ES2320645T5/en not_active Expired - Lifetime
- 2003-06-20 EP EP03738077.1A patent/EP1513922B2/en not_active Expired - Lifetime
- 2003-06-20 DK DK03738077.1T patent/DK1513922T4/en active
- 2003-06-20 EP EP20100174832 patent/EP2270191A1/en not_active Withdrawn
- 2003-06-20 EP EP10174816A patent/EP2269467A1/en not_active Withdrawn
- 2003-06-20 EP EP20183242.5A patent/EP3750406A1/en not_active Withdrawn
- 2003-06-20 CN CN201811093739.6A patent/CN109010854A/en active Pending
- 2003-06-20 EA EA201100701A patent/EA030476B1/en not_active IP Right Cessation
- 2003-06-20 DK DK16169170.4T patent/DK3111767T3/en active
- 2003-06-20 AT AT03738077T patent/ATE419330T1/en not_active IP Right Cessation
- 2003-06-20 CN CN038143828A patent/CN1662642B/en not_active Expired - Fee Related
- 2003-06-20 EP EP03740299.7A patent/EP1513941B1/en not_active Expired - Lifetime
- 2003-06-20 CN CN201010141591.6A patent/CN101837135B/en not_active Expired - Lifetime
- 2003-06-20 CN CN201010141738.1A patent/CN101837139B/en not_active Expired - Lifetime
- 2003-06-20 KR KR1020137024749A patent/KR101726477B1/en active IP Right Grant
- 2003-06-20 BR BRPI0311906A patent/BRPI0311906B1/en active IP Right Grant
- 2003-06-20 JP JP2004514829A patent/JP2005529621A/en active Pending
- 2003-06-20 EP EP10174820A patent/EP2255667A1/en not_active Ceased
- 2003-06-20 KR KR20047020626A patent/KR20050013584A/en not_active Application Discontinuation
- 2003-06-20 DE DE60325590T patent/DE60325590D1/en not_active Expired - Lifetime
- 2003-06-20 WO PCT/EP2003/006553 patent/WO2004001021A1/en active Application Filing
- 2003-06-20 CA CA2489911A patent/CA2489911C/en not_active Expired - Lifetime
- 2003-06-20 EP EP10174818A patent/EP2255666A1/en not_active Withdrawn
- 2003-06-20 EP EP08157460A patent/EP1970438A1/en not_active Withdrawn
- 2003-06-20 EP EP16169170.4A patent/EP3111767B1/en not_active Expired - Lifetime
- 2003-06-20 EP EP10174814A patent/EP2258207A1/en not_active Withdrawn
- 2003-06-20 KR KR1020177002759A patent/KR101965078B1/en active IP Right Grant
- 2003-06-20 KR KR1020117002510A patent/KR20110017017A/en not_active Application Discontinuation
- 2003-06-20 KR KR1020207018939A patent/KR102254453B1/en active IP Right Grant
- 2003-06-20 AU AU2003245978A patent/AU2003245978A1/en not_active Abandoned
- 2003-06-20 ES ES16169170T patent/ES2712854T3/en not_active Expired - Lifetime
-
2004
- 2004-12-02 IL IL165530A patent/IL165530A/en active IP Right Grant
-
2009
- 2009-03-09 US US12/382,103 patent/US8217151B2/en not_active Expired - Lifetime
- 2009-11-26 IL IL202364A patent/IL202364A0/en unknown
-
2010
- 2010-03-01 JP JP2010044460A patent/JP2010187676A/en active Pending
-
2012
- 2012-05-09 US US13/467,858 patent/US20120283461A1/en not_active Abandoned
- 2012-05-09 US US13/467,843 patent/US8895708B2/en not_active Expired - Lifetime
- 2012-11-15 JP JP2012251460A patent/JP2013078590A/en active Pending
-
2013
- 2013-08-02 JP JP2013161618A patent/JP6214270B2/en not_active Expired - Lifetime
-
2014
- 2014-06-23 US US14/311,461 patent/US9457108B2/en not_active Expired - Lifetime
-
2015
- 2015-05-12 HK HK15104471.3A patent/HK1203856A1/en unknown
- 2015-05-22 HK HK15104897.9A patent/HK1204296A1/en unknown
- 2015-09-14 JP JP2015180892A patent/JP2016028588A/en active Pending
-
2016
- 2016-08-26 US US15/248,065 patent/US10493174B2/en not_active Expired - Lifetime
-
2017
- 2017-11-13 JP JP2017218086A patent/JP6665147B2/en not_active Expired - Lifetime
-
2019
- 2019-04-25 JP JP2019084173A patent/JP2019162116A/en active Pending
- 2019-10-16 US US16/654,713 patent/US11083808B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11083808B2 (en) | Pasteurisation process for microbial cells and microbial oil | |
EA039406B1 (en) | Pasteurisation process for microbial cells and microbial oil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |